Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Boston Scientific is looking to join rhythm management rivals St. Jude Medical and Medtronic with its own truly leadless pacemaker, which is being developed to complement its S-ICD line, Dr. Ken Stein told MassDevice.com last week at the annual Heart Rhythm Society meeting in Boston.
Stein said development work on the as-yet-unnamed leadless pacer should be complete next year. It’s being built “from the ground up” for 2-way communication with Boston’s S-ICD devices, he told us. Read more
OthoSpace said that it completed “significant” but unspecified financing for its InSpace biodegradable orthopedic balloon, led by Healthpoint Capital with participation from Smith & Nephew and Triventures.
The InSpace device is a minimally invasive orthopedic balloon designed for use in rotator cuff repairs. Read more
EnteroMedics said that the first commercial patient has been implanted with its Maestro neurostimulation anti-obesity implant.
The surgery took place at Tufts Medical Center in Boston May 13, performed by Dr. Sajani Shah, EnteroMedics said. Read more